B
L020
vs
D
DAX Index
Over the past 12 months, L020 has significantly outperformed DAX Index, delivering a return of +88% compared to the DAX Index's +12% growth.
Stocks Performance
L020 vs DAX Index
Performance Gap
L020 vs DAX Index
Performance By Year
L020 vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Britannia Life Sciences Inc
Glance View
Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.
